RxDoctor Payments Data

Trevor Mattarella

Family · Pigeon, MINPI 1104337344

Payments from drug & device makers

$7,309in general payments, 2019–2025

Across 307 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Axsome Therapeutics, Inc.$891
  • Otsuka America Pharmaceutical, Inc.$538
  • Bayer$378
  • Amgen$317
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$7,20999%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,309 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$24,325
MounjaroTirzepatide20$20,382
EliquisApixaban11$17,233
Atorvastatin Calcium57$682
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$534
Albuterol Sulfate HfaAlbuterol Sulfate17$506
Potassium Chloride17$503
Valsartan12$491
Chlorthalidone21$379
Rosuvastatin Calcium13$359
Lisinopril45$327
Metformin Hcl28$321
Methylprednisolone60$271
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$245
Amlodipine Besylate32$217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,399$24,32526 claims
Lilly USA, LLCMounjaro$269$20,38220 claims
PfizerEliquis$81$17,23311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.

Other family in Pigeon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →